Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRA2A | P08913 | 9/20 | 1.00 |
| ▸ | ADRA1A | P35348 | 8/20 | 1.00 |
| ▸ | CYP2D6 | P10635 | 7/20 | 1.00 |
| ▸ | ADRA2C | P18825 | 6/20 | 1.00 |
| ▸ | ADRA2B | P18089 | 5/20 | 1.00 |
| ▸ | ADRA1B | P35368 | 4/20 | 1.00 |
| ▸ | MEN1 | O00255 | 3/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 3/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 3/20 | 1.00 |
| ▸ | ADRA1D | P25100 | 3/20 | 1.00 |
| ▸ | PMP22 | Q01453 | 3/20 | 1.00 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 1.00 |
| ▸ | LMNA | P02545 | 2/20 | 1.00 |
| ▸ | CYP1A2 | P05177 | 2/20 | 1.00 |
| ▸ | TSHR | P16473 | 2/20 | 1.00 |
| ▸ | HTR1A | P08908 | 2/20 | 1.00 |
| ▸ | THRB | P10828 | 2/20 | 1.00 |
| ▸ | HPGD | P15428 | 2/20 | 1.00 |
| ▸ | HTR1B | P28222 | 2/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Rauwolscine SCHEMBL12648480 | 1.00 | ADRA2A (1.00) | ADRA2AADRA1ACYP2D6ADRA2CADRA2B | |
| Rauwolscine SCHEMBL4548294 | 1.00 | ADRA2A (1.00) | ADRA2AADRA1ACYP2D6ADRA2CADRA2B | |
| Rauwolscine SCHEMBL7945869 | 1.00 | ADRA2A (1.00) | ADRA2AADRA1ACYP2D6ADRA2CADRA2B | |
| Rauwolscine SCHEMBL25366080 | 1.00 | ADRA2A (1.00) | ADRA2AADRA1ACYP2D6ADRA2CADRA2B | |
| Rauwolscine SCHEMBL6700479 | 1.00 | ADRA2A (1.00) | ADRA2AADRA1ACYP2D6ADRA2CADRA2B | |
| Rauwolscine SCHEMBL23244673 | 1.00 | ADRA2A (1.00) | ADRA2AADRA1ACYP2D6ADRA2CADRA2B | |
| Rauwolscine SCHEMBL564021 | 1.00 | ADRA2A (1.00) | ADRA2AADRA1ACYP2D6ADRA2CADRA2B | |
| Rauwolscine SCHEMBL18541713 | 1.00 | ADRA2A (1.00) | ADRA2AADRA1ACYP2D6ADRA2CADRA2B | |
| Rauwolscine SCHEMBL22703462 | 1.00 | ADRA2A (1.00) | ADRA2AADRA1ACYP2D6ADRA2CADRA2B | |
| Rauwolscine SCHEMBL244514 | 1.00 | ADRA2A (1.00) | ADRA2AADRA1ACYP2D6ADRA2CADRA2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3220942-A1 | METHODS AND COMPOSITIONS COMPRISING DESMOPRESSIN IN COMBINATION WITH AN ALPHA-ADRENERGIC RECEPTOR ANTAGONIST | Serenity Pharmaceuticals LLC (US) | 2017-09-27 | — | — | EP | disclosed |
| WO-2016081772-A1 | METHODS AND COMPOSITIONS COMPRISING DESMOPRESSIN IN COMBINATION WITH AN ALPHA-ADRENERGIC RECEPTOR ANTAGONIST | ALLERGAN, INC. (US) | 2016-05-26 | — | — | WO | disclosed |
| EP-0710479-B1 | Use of a serotonin agonist in combination with a tachykinin receptor antagonist for the manufacture of a medicament for the treatment or prevention of migraine | LILLY CO ELI (US) | 1999-01-07 | — | — | EP | disclosed |
| US-5744482-A | Serotonin agonist in combination with a tachykinin receptor antagonist in the treatment or prevention of migraine | ELI LILLY AND COMPANY (US) | 1998-04-28 | — | — | US | disclosed |
| US-5698444-A | ISOLATED AMINO ACID COMPOUND | ELI LILLY AND COMPANY (US) | 1997-12-16 | — | — | US | disclosed |
| WO-1996041633-A1 | METHODS OF TREATING COLD AND ALLERGIC RHINITIS | ELI LILLY AND COMPANY (US) | 1996-12-27 | — | — | WO | disclosed |
| EP-0747049-A1 | Use of tachykinin antagonists in combination with serotonin agonists or serotonin reuptake inhibitors for the manufacture of a medicament for the treatment of allergic rhinitis | ELI LILLY AND COMPANY (US) | 1996-12-11 | — | — | EP | disclosed |
| WO-1996029074-A1 | METHODS OF TREATING OR PREVENTING PAIN OR NOCICEPTION | ELI LILLY AND COMPANY (US) | 1996-09-26 | — | — | WO | disclosed |
| WO-1996024353-A1 | METHODS OF TREATING OR PREVENTING PSYCHIATRIC DISORDERS | ELI LILLY AND COMPANY (US) | 1996-08-15 | — | — | WO | disclosed |
| EP-0710479-A1 | Use of a serotonin agonist in combination with a tachykinin receptor antagonist for the manufacture of a medicament for the treatment or prevention of migraine | ELI LILLY AND COMPANY (US) | 1996-05-08 | — | — | EP | disclosed |
| WO-1996011000-A1 | METHODS OF TREATING MIGRAINE | ELI LILLY AND COMPANY (US) | 1996-04-18 | — | — | WO | disclosed |
| US-4532135-A | Treating renal damage by administering vasodilator having postsynaptic alpha-adrenoceptor blocking activity and antihyperlipidemic characteristics | EDWARDS K DAVID G | 1985-07-30 | — | — | US | disclosed |